---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-003203"
form_type: "8-K"
ticker: "XBIO"
cik: "0001534525"
company_name: "Xenetic Biosciences, Inc."
filed_at: "2023-05-11T23:59:59+00:00"
generated_at: "2026-06-15T04:04:52.547447+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Xenetic Biosciences Q1 net loss $0.9M; cash $12M; Takeda royalties up 55.7%

## Summary
- Net loss of $0.9M for Q1 2023; R&D expenses down 46% to $0.6M from $1.1M.
- Royalty payments from Takeda sublicense increased 55.7% to $0.6M.
- Ended quarter with $12.0M cash; advancing DNase oncology program.
- Entered collaboration with Scripps Research Institute for DNase and CAR T programs.
- Appointed Scott N. Cullison and Reid P. Bissonnette to support DNase platform.

## SEC filing metadata
- accession: 0001683168-23-003203
- form_type: 8-K
- ticker: XBIO
- cik: 0001534525
- company_name: Xenetic Biosciences, Inc.
- filed_at: 2023-05-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534525/000168316823003203/0001683168-23-003203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534525/000168316823003203/xenetic_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-003203
- JSON: https://secwatch.observer/filing/0001683168-23-003203.json
- Plain text: https://secwatch.observer/filing/0001683168-23-003203.txt

## Key facts
- Earnings Releases
  Xenetic Biosciences, Inc. reported three months ended March 31, 2023 results: net income approximately $0.9 million.
  - Period: three months ended March 31, 2023
  - Net income: approximately $0.9 million
  - Result: reported results
  source text: Net loss for the quarter ended March 31, 2023 was approximately $0.9 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534525/000168316823003203/0001683168-23-003203-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.